Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
36112968
DOI
10.1182/blood.2022016963
PII: S0006-4971(22)01278-2
Knihovny.cz E-zdroje
- MeSH
- akutní myeloidní leukemie * farmakoterapie etiologie MeSH
- cytarabin MeSH
- lidé MeSH
- následné studie MeSH
- protokoly protinádorové kombinované chemoterapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- cytarabin MeSH
Almazov National Medical Research Center Saint Petersburg Russia
Centre Hospitalier Le Mans Le Mans France
Chinese Academy of Medical Sciences Tianjin China
CIUSSS EMTL Installation Maisonneuve Rosemont Montreal Quebec City Canada
Department of Leukemia The University of Texas MD Anderson Cancer Center Houston TX
Eastern Health and Monash University Melbourne Victoria Australia
Evaggelismos General Hospital Athens Greece
George Papanicolaou General Hospital Thessalonica Greece
Heartlands Hospital Birmingham United Kingdom
Hubertus Wald University Cancer Center University Medical Center Hamburg Eppendorf Hamburg Germany
National and Kapodistrian University of Athens Medical School Laiko General Hospital Athens Greece
Netcare Pretoria East Hospital Moreletapark Pretoria South Africa
Norton Cancer Institute Louisville KY
Seoul National University Hospital Seoul Republic of Korea
University of Fukui Hospital Fukui Japan
University of Pittsburgh Medical Center Cancer Center Pittsburgh PA
Citace poskytuje Crossref.org
